07:06 AM EDT, 08/29/2025 (MT Newswires) -- Rakovina Therapeutics ( RKVTF ) overnight Thursday said its second-quarter net loss widened on higher expenses.

The company, which is advancing cancer therapies through AI, said net loss jumped to $2.9 million, or $0.18 per share, from $0.8 million, or $0.12 per share, in the prior year period.

Research & development expenses increased by over $1.1 million, to $1.6 million, while general and administrative expenses rose by $1 million.